Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 10—October 2026
Research
Detection of Anaplasma capra in Patients with Suspected Crimean-Congo Hemorrhagic Fever, Turkey, 2022
Table 1
Primers used for amplification of the gltA and groEL genes of Anaplasma capra recovered from patients with anaplasmosis, Turkey
| Target gene | Primer name | Primer sequence, 5′ → 3′ | Amplified product size, bp | Reference |
|---|---|---|---|---|
| gltA |
Outer-f | GCGATTTTAGAGTGYGGAGATTG | 1,031 | (19) |
| Outer-r | TACAATACCGGAGTAAAAGTCAA | |||
| Inner-f | TCATCTCCTGTTGCACGGTGCCC | 594 |
(23) |
|
| Inner-r |
CTCTGAATGAACATGCCCACCCT |
|||
| groEL | Outer-f | GCG AGG CGT TAG ACA AGT CCATT | 1,129 | (19) |
| Outer-r | TCC AGA GAT GCA AGC GTG TATAG | |||
| Inner-f | TGA AGA GCA TCA AAC CCG AAG | 874 | (23) | |
| Inner-r | CTG CTC GTG ATG CTA TCG G |
1These first authors contributed equally to this article.
Page created: August 05, 2026
Page updated: September 16, 2026
Page reviewed: September 16, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.